| Previous Section | Index | Home Page |
National Blood Authority
34. Mrs. Dean: To ask the Secretary of State for Health if he will make a statement on the work of the National Blood Authority. [142929]
38. Mr. Jenkins: To ask the Secretary of State for Health if he will make a statement on the work of the National Blood Authority. [142933]
Mr. Denham: The National Blood Authority (NBA) is a vital part of the National Health Service and, as such is expected to provide high quality, cost efficient services. Over the past two years the NBA has introduced new
9 Jan 2001 : Column: 531W
initiatives to ensure that the quality and safety of blood for patients is maintained and improved and that NHS demand for blood components is fully met.
Southend General Hospital
37. Sir Teddy Taylor: To ask the Secretary of State for Health if he will make a statement on the waiting lists for surgery at the Southend general hospital. [142932]
Mr. Denham: The number of patients waiting for surgery at Southend General Hospital have been affected by a combination of factors, the most significant being the increase in general practitioner referrals reflecting the development of new and enhanced service and emergency admissions which have affected elective surgical admissions. Southend Hospital National Health Service Trust is working with its other health partners and social services on ways to address this in both the hospital and the community.
Pay and Conditions (NHS Staff)
39. Mr. Hendrick: To ask the Secretary of State for Health what plans he has to improve the pay and conditions of NHS staff. [142934]
Mr. Denham: The NHS Plan sets out our proposals for improving the pay and conditions of all staff working in the National Health Service. Copies are available in the Library.
Waiting List Statistics
40. Mrs. Roe: To ask the Secretary of State for Health if he will make a statement about the way that NHS waiting list statistics are compiled. [142935]
Mr. Denham: We continue to collect waiting list statistics in the same way as the previous Administration.
Hip Replacements
Mr. Jim Cunningham: To ask the Secretary of State for Health how many hip replacement operations took place in the NHS over the last 12 months; and what was the average cost. [142908]
Mr. Denham: In 1998-99 there were 37,189 primary total hip replacements. The average cost was £3,755.
There were also 4,013 revision of hip replacement operations, costing an average of £5,046.
Variant CJD
Mr. Wigley: To ask the Secretary of State for Health what the estimated expenditure is in the current year on research work aimed at funding a drug or vaccine to control variant CJD; and what plans he has to increase his expenditure next year. [141375]
Yvette Cooper: The Department has allocated some £100,000 of funding in each of the financial years 2000-01 and 2001-02 to research projects specifically to address the development of drugs for the treatment or control of variant Creutzfeldt-Jakob Disease. The Medical Research Council, together with the Department, remains ready to consider proposals for funding suitable research in this field.
9 Jan 2001 : Column: 532W
Last year we dedicated some £31.5 million into research into transmissible spongiform encephalopathies. Of this, some £4 million was dedicated to diagnostics, treatment and prevention.
Mr. Yeo: To ask the Secretary of State for Health what research the Government are funding into the possibility of vCJD infection by means other than the consumption of beef. [144372]
Yvette Cooper [holding answer 8 January 2001]: The Government rely on the Spongiform Encephalopathy Advisory Committee (SEAC) for advice on matters concerning BSE and variant Creutzfeld Jakob Disease (vCJD). SEAC has concluded that BSE and vCJD are caused by prion strains that are currently indistinguishable, and considers vCJD to be an acquired prion disease caused by exposure to BSE or a BSE-like agent.
The Government are prepared to consider the funding of any proposals for research into possible explanations for BSE and vCJD, which should be submitted for consideration through the normal channels. Experiments are currently under way to look further into the theoretical possibility of transmission of vCJD via surgical instruments, or via blood. A hypothesis that BSE might be caused by an abnormal immune response is also being investigated. In addition, the Department of Health- funded National CJD Surveillance Unit follows up medical, immunological, occupational and residential histories of vCJD patients, as well as their dietary habits, on an ongoing basis to identify any common factors. The results are published in the unit's annual report.
Strokes
Mr. Jack: To ask the Secretary of State for Health (1) if he will list the research projects into strokes which have been supported by Government bodies; and what was the individual level of expenditure for each project; [143247]
- (2) if he will make a statement on his plans for financing research into strokes for the next three financial years. [143135]
Mr. Denham: The main Government agency for research into the causes of and treatments for disease is the Medical Research Council (MRC) which receives its funding via the Department of Trade and Industry. The Department funds research to support policy and the delivery of effective practice in the National Health Service. The Department also provides NHS support funding for research commissioned by the research councils and charities that takes place in the NHS.
The research projects into stroke which have been supported by the Department are listed.
- Project: British Regional Heart Study: a prospective study into the causes of CHD, hypertension and stroke in a cohort of men now aged about 60-79--Professor Peter Whincup, St. George's Medical School.
Cost: £324,674
Project: A related study in a cohort of women of similar age--Professor Shah Ebrahim, University of Bristol.
9 Jan 2001 : Column: 533W
Project title: A controlled comparison of alternative strategies in stroke rehabilitation--Professor Lalit Kalra, Guy's, King's and St. Thomas' School of Medicine.
Cost: £499,778
- Project title: A systematic review of the effectiveness, cost effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS--Professor Peter Sandercock, University of Edinburgh.
Cost: £77,482
Project title: What is the best imaging strategy for acute stroke?--Dr. Joanna Wardlaw, University of Edinburgh.
Cost: £131,415
Project title: Early prediction of rehabilitation needs following acute stroke--Professor Philip Bath, University of Nottingham.
Cost: £87,766
Project title: Social-environmental, psychological and physical approaches to stroke rehabilitation--Professor David Barer, University of Newcastle.
Cost: £371,264
Project title: Can the effectiveness of interdisciplinary team care for stroke be improved?--Professor David Barer, University of Newcastle.
Cost: £121,406
Project title: FOOD--A multicentre international randomised trial to evaluate percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients admitted to hospital with a recent stroke--Dr. Martin Dennis, University of Edinburgh.
Cost: £357,411
Project title: Screening for stroke--Professor Shah Ebrahim, University of Bristol.
Cost: £109,386
- Project title: Evaluating the effectiveness of acupuncture in defined aspects of stroke recovery--Dr. George Lewith.
Cost: £172,898
Project title: A study of the information-giving process between physiotherapists and patients in relation to recovery following stroke--Dr. Rose Wiles.
Cost: £40,621
Project title: A randomised trial to evaluate the cost effectiveness of a domiciliary rehabilitation scheme versus usual care in the rehabilitation of stroke patients--Dr. Paul Roderick.
Cost: £127,522
Project title: An exploration of the narrative life histories of people following stroke--Dr. Caroline Ellis-Hill.
Cost: £48,750
Project title: The Development and Evaluation of the provision of individualised information to meet the needs of people undergoing rehabilitation following a stroke--Professor D. L. McEllan.
Cost: £29,036
Project title: To evaluate the assessment of motor and process skills (AMPs) as an improved measure of rehabilitation outcome in stroke patients--Ms Susanna Robinson.
Cost: £20,504
Project: Developing methods in primary care for prevention of vascular disease and diabetes in high risk ethnic groups-- Dr. J. K. Cruikshank, University of Manchester.
Cost: £127,151
- Project: Formulation of guidelines for dental rehabilitation of stroke patients--Professor James McCord, University Dental Hospital of Manchester.
Cost: £13,525
Project: The Oxford community myocardial infarction incidence study--Dr. Andrew Neil, University of Oxford.
Cost: £125, 934
Project: Development of an early hospital discharge policy following acute stroke--an evaluation--Dr. Heather Rodgers, University of Newcastle.
9 Jan 2001 : Column: 534W
Project: An RCT of the cost-effectiveness of exercise in the over 65s--Professor Jonathan Nicholl, University of Sheffield.
Cost: £334,188
Project: The Tees stroke register--Professor Richard Thompson, University of Newcastle.
Cost: £463,093
Project: Co-ordinated stroke audit and research (COSTAR)--Professor David Barer, Newcastle General Hospital.
Cost: £174,210
Project: Rehabilitation of arm function--Professor Nadina Lincoln, University of Nottingham.
Cost: £215,007
Project: The incidence, natural history, resource use and outcome of stroke--Dr. Charles Wolfe, United Medical and Dental School.
Cost: £607,088
- Project: Snoring, obstructive sleep apnoea stroke--Professor G. J. Gibson, Freeman Hospital.
Cost: £86,147
Project: Does psychological treatment improve the outcome after stroke?--Professor Allan House, University of Leeds.
Cost: £349,163
Project: Development of a measure of social outcome following stroke--Mrs. Victoria Wood, Royal United Hospital Bath NHS Trust.
Cost: £63,501
Project: The incidence of, aetiology and management of stroke--Dr. I. Baker, University of Bristol.
Cost: £281,268
Project: Multi-centre trial of out patient occupational therapy of stroke--Dr. John Gladman, University of Nottingham.
Cost: £206,748
Project: The influence of developmental indices and blood pressure in young adults on risk of stroke and ischaemic heart disease in later life--Professor George Davey Smith, University of Bristol.
Cost: £54,862
Project: The treatment of urinary incontinence in stroke patients--Professor Christopher Castleder, University of Leicester.
Cost: £96,271.
- Project: The molecular basis of brain damage during and after cerebral ischaemia--Dr. T. E. Bates, Institute of Neurology.
Cost: £148,235
Project: Meta-Analsis of Prospective studies to establish risk factors for stroke--Dr. N. Qizilbash, University of Oxford.
Cost: £147,894
Project: The International Stroke Trial--Professor P. Sandercock, University of Edinburgh.
Cost: £281,072
Project: The treatment of transient ischaemic attacks and stroke--Professor C. P. Warlow, University of Edinburgh.
Cost: £2,140,565
Project: Chemokines and metalloproteinases in leukocytes adhesion and migration in the central nervous system during inflammation--Professor M. L. Cuzner, Institute of Neurology.
9 Jan 2001 : Column: 535W
Project: The molecular basis of brain damage during and after cerebral ischaemia--Dr. K. L. Allen, Institute of Neurology.
Cost: £148,383
Project: Characterisation of endothelin receptor sub-types in human cerebral vessels--Dr. A. P. Davenport, University of Cambridge.
Cost: £47,982
- Project: Computer assisted image analysis of hypertensive retinal vascular architecture--Dr. S. A. Thorn, St. Mary's Hospital.
Cost: £98,951
Project: Protective effect of heart shock protein over-expression in cerebral ischaemia--Professor David Latchman, University College London.
Cost: £73,758
Project: Control of expression of the angiotensinogen gene and its linkage to hypertension and Cerebrovascular disease--Professor P. J. Grant, University of Leeds.
Cost: £132,631
Project: Brain TNF alpha receptors--Professor N. J. Rothwell, University of Manchester.
Cost: £144,990
Project: Mechanisms of damage to and protection of non-neuronal cells in the CNS during cerebral ischaemia--Professor J. McCulloch, University of Glasgow.
Cost: £116,111
Project: Neuropeptide-Y and induced tolerance of excitotoxic insults--Dr. L. E. Sundstrom, University of Southampton.
Cost: £39,194
Project: Ion channels, transporters and receptors in brain endothelium: basic science to underpin drug discovery--Dr. J. N. Abbott, Kings College London.
Cost: £154,035
- Project: A study of the effects of stroke on the development of reading in children--Professor E. Funnell, Royal Holloway and Bedford New College.
Cost: £132,538
Project: Clinical and pathological studies of acute ischaemic stroke--Professor C. P. Warlow, University of Edinburgh.
Cost: £578,072
Project: The causes, consequences and treatment of acute brain injury--Professor C. P. Warlow, University of Edinburgh.
Cost: £1,601,033
Project: The treatment and prevention of stroke--Professor P. Sandercock, University of Edinburgh.
Cost: £645,824
Project: Pilot study for a randomised controlled trial of corticosteroids in head injury--Dr. I. G. Roberts Institute of Child Health (London).
Cost: £277,744
Project: The effect of nitric oxide donors on experimental stroke--Professor P. M. W. Bath, GKT, King's College Campus.
Cost: £175,716
Project: Mechanisms of delayed ischaemic neurological deficit following aneurysmal subarachnoid haemorrhage--Dr. D. K. Menon, University of Cambridge.
Cost: £25,404
Project: Regulation of brain IL-1 release--Professor N. J. Rothwell, University of Manchester.
Cost: £44,496
- Project: The asymptomatic carotid surgery trial--Miss A. Halliday, St. Mary's Hospital.
Cost: £526,685
Project: The Cambridge Cerebrovascular Centre--genetic predisposition, vascular biology, Functional Imaging--Professor J. D. Pickard, University of Cambridge.
Cost: £4,101,451
Project: Surgical Trial in Intracerebral Haemorrhage--Professor A. D. Mendelow, University of Newcastle.
9 Jan 2001 : Column: 536W
Project: Acute and Chronic Brain Injury--Mechanisms and Outcome: Wolfson Brain Imaging Centre--Professor J. D. Pickard, University of Cambridge.
Cost: £1,583,194
Project: Functional and Metabolic Magnetic Resonance Imaging of the Brain During the Acute and Recovery Stages of Stroke--Professor P. M. Mathews, University of Oxford.
Cost: £1,373,622
Project: Investigation of calpain function in slice cultures using noval fluorescent probes--Professor M. Bradley, University of Southampton.
Cost: £156,100
Project: Brain Protection after Cerebral Ischaemia--Professor J. McCulloch, University of Glasgow.
Cost: £221,212
Project: Intravenous Magnesium Efficacy in Stroke Study (IMAGES)--Dr. K. R. Lees, University of Glasgow.
- Cost: £1,394,970
Project: Asymptomatic Carotid Surgery Trial--Miss A. Halliday, St. Mary's Hospital.
Cost: £631,816
Project: Brain Damage Co-operative: from Mechanisms to Man--Professor McCulloch, University of Glasgow.
Cost: £209,586
Project: Neuronal pathways underlying CNS responses to injury and disease--Professor N. J. Rothwell, University of Manchester.
Cost: £429,332
Project: The pathophysiology of clinical recovery and deterioration after ischaemic stroke: Studies with functional/ physiologic--Professor J. Baron, University of Cambridge.
Cost: £1,000,004
Project: The CRASH trial (Corticosteroid randomisation after significant head injury)--Dr. I. G. Roberts, Institute of Child Health (London).
Cost: £2,210,337.
Much of MRC's work is in response mode, so it is not possible to predict spend over the next three years. However, MRC do not anticipate any major change in the level of commitment.
| Next Section | Index | Home Page |